In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant ...

Get Organized with the Home Edit” star Clea Shearer opens up about how she finds new meaning in life two years after being ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...

Summit Therapeutics’ ivonescimab has the potential to challenge Merck’s blockbuster checkpoint inhibitor in non-small cell ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, new research finds.

Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...

Researchers have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients. The findings show two distinct patterns of B cell ...

Peter Schmid, MD, PhD, discusses his key takeaways from the phase 3 KEYNOTE-522 trial and the updated findings presented at ...

Patients with early-stage triple-negative breast cancer tended to have improved survival with neoadjuvant pembrolizumab plus ...

Prior to KEYNOTE-522 becoming the new standard of care, the standard treatment for triple-negative breast cancer was preoperative chemotherapy followed by surgery, and that allowed us to see how well ...